Amprenavir Patent Expiration
Amprenavir is Used for managing HIV infection. It was first introduced by Glaxosmithkline
Amprenavir Patents
Given below is the list of patents protecting Amprenavir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Agenerase | US6730679 | Pharmaceutical formulations |
Nov 11, 2017
(Expired) | Glaxosmithkline |
| Agenerase | US5723490 | THF-containing sulfonamide inhibitors of aspartyl protease |
Mar 03, 2015
(Expired) | Glaxosmithkline |
| Agenerase | US5646180 | Treatment of the CNS effects of HIV |
Jul 08, 2014
(Expired) | Glaxosmithkline |
| Agenerase | US5585397 | Sulfonamide inhibitors of aspartyl protease |
Dec 17, 2013
(Expired) | Glaxosmithkline |
Amprenavir's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List